The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Bertz S, Otto W, Denzinger S, et al. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer[J]. European urology, 2014, 65(1): 218-226. PMID:22633802 [pmid]
2. Meng X, Hu H, Wang Y, et al. Application of bi-planar reduced field-of-view DWI (rFOV DWI) in the assessment of muscle-invasiveness of bladder cancer[J]. European Journal of Radiology, 2021, 136: 109486. PMID:33434861 [pmid]
3. Bruch P G, Plage H, Hofbauer S, et al. Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder[J]. Experimental and molecular pathology, 2023, 131: 104860. PMID:36997051 [pmid]
4. Xu S, Yao Q, Liu G, et al. Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer[J]. European radiology, 2020, 30(3): 1804-1812. PMID:31773297 [pmid]
5. Wang F, Wu L M, Hua X L, et al. Intravoxel incoherent motion diffusion‐weighted imaging in assessing bladder cancer invasiveness and cell proliferation[J]. Journal of Magnetic Resonance Imaging, 2018, 47(4): 1054-1060. PMID:28815808 [pmid]